Terms: = Skin cancer AND SDC4, ENSG00000124145, 6385, P31431, SYND4, MGC22217
4 results:
1. Proteomic profiling of cutaneous melanoma explains the aggressiveness of distant organ metastasis.
Azimi A; Patrick E; Teh R; Kim J; Fernandez-Penas P
Exp Dermatol; 2023 Jul; 32(7):1072-1084. PubMed ID: 37082900
[TBL] [Abstract] [Full Text] [Related]
2. Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progression.
Gerber U; Hoß SG; Shteingauz A; Jüngel E; Jakubzig B; Ilan N; Blaheta R; Schlesinger M; Vlodavsky I; Bendas G
Semin Thromb Hemost; 2015 Mar; 41(2):244-54. PubMed ID: 25682080
[TBL] [Abstract] [Full Text] [Related]
3. Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.
Ridgway LD; Wetzel MD; Marchetti D
J Cell Biochem; 2010 Dec; 111(5):1299-309. PubMed ID: 20803552
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of structural properties for morphological differentiation of melanosomes: II. Electron microscopic and SDS-PAGE comparison of melanosomal matrix proteins in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1982 Jan; 78(1):76-81. PubMed ID: 7054310
[TBL] [Abstract] [Full Text] [Related]
